We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
-2.31%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$25.1B
AUM Growth
-$1.52B
Cap. Flow
-$491M
Cap. Flow %
-1.96%
Top 10 Hldgs %
22.13%
Holding
697
New
161
Increased
139
Reduced
161
Closed
204

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$563M
2
MSFT icon
Microsoft
MSFT
+$408M
3
CRM icon
Salesforce
CRM
+$308M
4
EA
Electronic Arts
EA
+$210M
5
W icon
Wayfair
W
+$198M

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$876M
2
META icon
Meta Platforms (Facebook)
META
+$445M
3
BABA icon
Alibaba
BABA
+$417M
4
BA icon
Boeing
BA
+$333M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$321M

Sector Composition

Rank Sector Weight
1 Technology 21.42%
2 Consumer Discretionary 12.56%
3 Healthcare 10.34%
4 Industrials 10.11%
5 Real Estate 7.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADTN icon
376
Adtran
ADTN
$622M
$3.88M 0.02%
+445,264
New +$4.48M
GPGI
377
GPGI Inc
GPGI
$4.16B
$3.88M 0.02%
356,556
+1,251
+0.4% +$15.4K
ATYR
378
aTyr Pharma
ATYR
$51.9M
$3.86M 0.02%
1,277,897
-544
-0% -$1.98K
NKTX icon
379
Nkarta
NKTX
$176M
$3.8M 0.02%
2,064,956
+730,260
+55% +$1.5M
DEC
380
Diversified Energy Company
DEC
$1.01B
$3.74M 0.01%
276,740
+199,387
+258% +$2.95M
LENZ
381
LENZ Therapeutics
LENZ
$168M
$3.65M 0.01%
142,113
– –
SPRY icon
382
ARS Pharmaceuticals
SPRY
$587M
$3.65M 0.01%
290,092
-963,632
-77% -$11.6M
NUVL
383
DELISTED
Nuvalent
NUVL
$3.64M 0.01%
51,303
-51,302
-50% -$4.01M
NI icon
384
NiSource
NI
$20B
$3.58M 0.01%
89,313
+8,919
+11% +$344K
VSTS icon
385
Vestis
VSTS
$1.83B
$3.56M 0.01%
359,694
-1,333,549
-79% -$17.7M
SO icon
386
Southern Company
SO
$105B
$3.52M 0.01%
+38,230
New +$3.31M
GDS icon
387
GDS Holdings
GDS
$6.29B
$3.48M 0.01%
137,253
+8,075
+6% +$245K
ALGS icon
388
Aligos Therapeutics
ALGS
$47.8M
$3.4M 0.01%
+412,000
New +$9.03M
APLS
389
DELISTED
Apellis Pharmaceuticals
APLS
$3.28M 0.01%
+150,000
New +$4.14M
OKLO
390
Oklo
OKLO
$8.28B
$3.24M 0.01%
150,000
-1,056,281
-88% -$35.7M
INN
391
Summit Hotel Properties
INN
$670M
$3.24M 0.01%
598,819
– –
ELDN icon
392
Eledon Pharmaceuticals
ELDN
$284M
$3.16M 0.01%
933,475
– –
LRMR icon
393
Larimar Therapeutics
LRMR
$417M
$3.1M 0.01%
1,442,473
+458,396
+47% +$1.45M
REE
394
DELISTED
REE Automotive
REE
$3.08M 0.01%
+1,159,750
New +$8.33M
CYTK icon
395
Cytokinetics
CYTK
$10.8B
$3.01M 0.01%
75,000
-75,000
-50% -$3.45M
SMR icon
396
NuScale Power
SMR
$3.77B
$3.01M 0.01%
212,716
-212,715
-50% -$4.3M
RNAM
397
DELISTED
Avidity Biosciences
RNAM
$2.95M 0.01%
100,000
+50,000
+100% +$1.56M
MRUS
398
DELISTED
Merus
MRUS
$2.87M 0.01%
68,182
-68,182
-50% -$2.97M
CVE icon
399
Cenovus Energy
CVE
$54.5B
$2.85M 0.01%
+204,786
New +$2.95M
LUCD icon
400
Lucid Diagnostics
LUCD
$183M
$2.81M 0.01%
+1,887,843
New +$2.27M
14 15
16
17 18

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q1 2025 Portfolio in Review

As of Q1 2025, Alyeska Investment Group held 697 positions worth $25.1B, down 5.7% from $26.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Alyeska Investment Group's Q1 2025 filing shows 161 new, 139 increased, 161 reduced and 204 closed positions. Its largest new stake was Salesforce: 988,971 shares worth $265M. The largest sale was iShares Core S&P 500 ETF, an estimated $876M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Alyeska Investment Group's largest Q1 2025 buy was Salesforce: 988,971 shares worth $265M.
  • Alyeska Investment Group added most to Amazon in Q1 2025, an estimated $563M increase.
  • Alyeska Investment Group's biggest Q1 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $876M.
  • Alyeska Investment Group fully exited Alphabet (Google) Class A in Q1 2025, selling an estimated $321M.
  • Alyeska Investment Group's ten largest holdings make up 22% of its $25.1B portfolio in Q1 2025.
  • Alyeska Investment Group opened 161 new positions and closed 204 in Q1 2025.
  • Alyeska Investment Group's portfolio value fell 5.7% quarter-over-quarter to $25.1B.

Based on Alyeska Investment Group's 13F filing for Q1 2025, filed 15 May 2025.